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The natural history of cervical cancer suggests that prevention can be achieved by 
modification of the host’s immune system through a nutrient-mediated program. This study 
reviews the preventive role of dietary intake on cervical intraepithelial neoplasia (CIN) 
induced by human papillomavirus (HPV). Electronic databases were searched using relevant 
keywords such as, but not limited to, “human papillomavirus infection”, “cervical 
intraepithelial neoplasia”, “lifestyle factors”, “nutrients intake” and “diet”. High consumption 
of fruit and vegetables appears to be protective against CIN. The findings also highlight the 
possibility of consuming high levels of specific nutrients, vitamins and minerals, and 
retaining sufficient level of these elements in the body, especially those with high 
antioxidants and antiviral properties, to prevent progression of transient and persistent HPV 
infections to high grade CIN 2 and 3 (including in situ cervical cancer). The protective effect 
is not significant for high risk HPV persistent infections and invasive cervical cancer. While 
it appears that intake of specific nutrients, vitamins and minerals may be good in CIN 
prevention, there is lack of evidence from controlled trial to confirm this. Health 
professionals shall focus on implementation of a balanced-diet prevention strategy at an early 









With a prevalence of 10%, cervical cancer is the second most common cancer (after breast 
cancer) affecting women around the world (1). While vaccination and safe sex education are 
effective in preventing the development of cervical intraepithelial neoplasia (CIN) to cervical 
cancer (2), women from many developing countries are not provided with such services. The 
morbidity rates of cervical cancer are therefore higher in these countries (3,4). It is predicted 
by 2020, if the risks and population growth remain constant as year 2002, there will be a 42% 
increase in cervical cancer cases (a total of 702,500 cases) if no novel preventive 
interventions are undertaken (3). The high incidence and cost to screen, treat and provide 




It is well established that deficiencies of dietary vitamins, minerals and nutrients can lead to 
DNA damage and immune-incompetence, permanent genetic alteration, and subsequently, a 
higher risk of cancer (6-11). New ‘nutrient-mediated’ prevention strategies are implemented 
to stimulate host’s cell-mediated immune response against the viral oncogenes E6 and E7 
(2,7). The constant expression and transforming properties of E6 and E7 genes and their 
interaction with the host cell proteins are indeed essential for the development of cervical 
cancer (12). The natural history of HPV infected high grade CIN to cervical cancer suggests 
that prevention can be stimulated via the immune system (12-15). The underlying principle of 
the ‘nutrient-mediated’ prevention strategy is the ability of a particular dietary constituent to 
interact with metabolising enzymes and proteins and regulate DNA methylation, synthesis 




Consuming foods, particularly plant-based foods, that support normal DNA methylation has 
the potential to suppress expression of viral oncogenes, promote proper signalling pathways, 
avoid cell transformation and reduce the risk of cancer in human (2,6,9). It has been 
documented that cruciferous vegetables have the ability to induce apoptosis through bioactive 
isothiocyanates and indoles (18-20). Vitamins such as vitamin A (retinoic acid), C (ascorbic 
acid), E (tocopherol) can inhibit proliferation of cancer cells (17,21), stabilise the p53 protein 
(9), prevent DNA damage and reduce immune-suppression (11,17,22), and support the 
receptor signal transduction pathways (22). The membrane-modifying effects of long chain 
fatty acids have also demonstrated positive effect in cancer prevention as docosahexaenoic 
acid induce mitochrondria-mediated apoptosis (23) and alter the receptor signal transduction 
pathway to activate lymphocyte proliferation (11). In addition, the active metabolite of 
vitamin D, 1,25-dihydroxyvitamin D3 was found to have the ability to avoid cell proliferation 
(10,24). The anti-viral property of minerals such as selenium and iron, while reliant on the 





Following HPV infection, it takes six years on average before progressing to high grade CIN 
including cervical cancer (5). Although the literature has suggested the role of diet in gene 
expression and cancer prevention, the relationship between a specific dietary constituent and 
the amount required to prevent cancer are not well established. Most of the studies were also 
based on animal models or in vitro. With the high disease burden of CIN, it is necessary to 
improve the understanding of dietary intake in the prevention of CINs and cervical cancer. 
The present review will examine recent evidence from epidemiological studies and 
randomized clinical trials with the aim to elucidate a better understanding about the role of 







MATERIAL AND METHODS 
 
A search was conducted on the MEDLINE and Web of Knowledge databases in February 
 
2012 to identify relevant articles. For the purpose of this review, the nomenclature used by 
the Australian Modified Bethesda System 2004 is followed; low grade CIN includes HPV 
infection (both transient and persistent infections), high grade CIN includes CIN 2 and 3 




Keywords used for searching the electronic databases were “human papillomavirus infection 
OR cervical cancer OR carcinoma in situ OR cervical intraepithelial neoplasia OR cervix 
neoplasia OR cervix neoplasm” AND “lifestyle factors OR diet OR foods and nutrients 
intake OR nutrition OR dietary intakes OR food groups OR vitamins OR minerals OR 
antioxidants OR anticancer OR immunological prevention” AND “cohort study OR case- 
control study OR cross-sectional study OR trial”. Only peer-reviewed, full-text articles 
written in English and published after the year 2000 were selected. The topic and abstract 
were initially screened to determine their eligibility for inclusion. Reference lists of the 
eligible articles were also manually searched for additional papers. The selection process 







Following the PRISMA approach, a total of 22 articles are selected (Figure 1). There are 
three cross-sectional studies, seven cohort studies, 11 case-control studies and one 
randomised controlled trial. The majority (95%) are observational studies, with about 48% 











The results are organized and presented in terms of whole food intake (Table 1), nutrients, 
minerals and vitamins intake (Table 2) and circulating plasma or serum nutrients (Table 3), in 
relation to the risk of HPV infection, CIN 1, 2 and 3. In the reviewed publications, the 
adjusted odds ratio estimated the association between the exposure variable of interest and 
the development of HPV infection and CIN, while accounting for the effects of other 






As summarised in Table 1, the epidemiological evidence suggested that high intake of certain 
whole foods may be protective against HPV transient infections. The results highlighted the 
benefits of high consumption of whole fruits and vegetables, nuts and fish. Meanwhile, low 
consumption of whole vegetables (including dark green-, dark yellow-, dark orange-coloured 
vegetables and cruciferous vegetables), fruits (including fruit juices), yogurt, tofu, fish and 
meat, are not protective against HPV persistent infection, CIN 1, 2 and 3. Low intakes of 
fruits and vegetables are associated with three-fold increase in the risk of CIN 2 and 3in 
subjects with high HPV viral load (27). Therefore, high risk patients, especially those 
infected by high risk HPV types, should increase and maintain their fruits and vegetables 
intake at moderate levels. This recommendation is supported by findings presented in Table 
2. Consumption of foods which provide rich sources of retinol and vitamin A, bioavailable 
calcium, antioxidants (including vitamin C, E, carotene, lutein and lycopene), as well as long 




We believe that the antioxidant and/or antiviral activities from these whole foods contribute 




Table 3 illustrates the relationship between circulating bioactive compounds (and their 
isomers) and risk of HPV-related diseases. The findings are consistent with the reported 
protective effects of nutrients, vitamins and minerals in Table 2. It appears that large amounts 
of whole foods should be consumed at an early stage to maximise their beneficial effect. For 
instance, circulating ascorbic acid (vitamin C) is not effective in preventing progression 
beyond HPV persistent infections. Similar results are observed between alpha tocopherol, 




Low serum levels of lycopene, retinol, alpha tocopherol and gamma tocopherol tended to be 
positively associated with risk of CIN 3, while medium to high levels of serum alpha- 
carotene, beta-cryptoxanthin, lutein/zeaxanthin, gamma tocopherol and particularly serum 
lycopene could reduce the risk of high grade CIN (Table 3). It has been suggested that some 
antioxidants may be effective in preventing high grade CIN if it was initiated from the stage 
of cervical inflammation that promoted HPV infections, rather than directly infected by HPV 
(28). Their molecular structures can interact with the receptors and substrates within the 
host’s cells and either regulate the activity of reactive oxygen species, which in turn inhibit 
transcription factor (activator protein, AP1) and expression of oncogenes E6 and E7, reduce 
immunosuppression, stabilise p53 protein, or prevent DNA damage (9,11,22,28). As a result, 





Vitamin A (retinoid acid) is essential for the replication of basal and mucous cells and 
synthesis of protein blocks (11). Vitamin A deficiency may thus lead to a higher risk of 
squamous metaplasia and infection. Therefore, a low-to-medium level of serum retinol is 
only effective in reducing the risk of low grade CIN I (Table 3). Retinoids have the ability to 
inhibit cell proliferation as their isoform retinoic acid receptors (RARβ2) stimulate the 
transcription of RARβ2 tumor suppressor, diminish formation of AP1 that regulates 
expression of oncogenes and prevent cell proliferation and induce apoptosis while enhancing 
the expression of p53 proteins (19). Consequently, sufficient amount of retinoic acids in the 




It is well known that folate plays an important role in DNA synthesis, repair, methylation and 
cell proliferation (29,30). Low folate levels are linked to weaker structure of DNA and thus 
more prone to DNA damage induced by virus and subsequent expression of the viral 
oncogene (17). As illustrated in Table 3, a low level of serum folate is associated with a 
higher risk of both low and high grade CIN, whereas medium levels of serum folate lead to a 
higher risk of low grade CIN but not high grade CIN. As folate can initiate DNA repair, 
methylation and expression of viral oncogenes, increasing the level of serum folate may 




Circulating antioxidants, at high levels, can enhance the clearance of high risk HPV 
 
infections and transient high risk HPV infections by up to 3 and 4 folds, respectively (Table 
 
3). In this regard, lycopene has emerged as the most effective. In contrast, as HPV infections 
evolve from transient to persistent, there is no significant increment in clearance of persistent 
HPV infections with any levels of plasma circulating nutrients. This relationship stresses the 




and minerals are important in regulating viral integration and gene stability and preventing 




It appears that high consumption of whole foods has little benefit for the prevention of 
persistent HPV infections and beyond (Table 1), which is consistent with other studies 
(17,22,31). It should be noted that these studies investigated the effect of a particular food 
group but not the whole spectrum of food groups. The World Cancer Research Fund 
recommends the consumption of a wide variety of whole foods, as they naturally contain 
various nutrients, vitamins, minerals and bioactive compounds not found in a specific type of 
supplement (32). The synergistic effect of all food groups was not examined in these studies, 
which could have masked the protective effect of whole food intake on HPV infections and 
CIN. Dietary supplements should only be taken by those with a specific nutritional deficiency 
rather than for the purpose of cancer prevention (32-34). In addition, the problem of 
‘collective error’ (33) should not be ignored. Moreover, explanation for the observed 
phenomenon cannot be elucidated without information on the history of the infection status 




Despite the emerging evidence from these studies, several limitations should be taken into 
consideration. Only one prospective study had investigated the association between nutrients 
and cervical cancer. The majority of the observational studies are prone to biases. These 
include information bias with reliance on a ‘standard serving’ of fruit and vegetables, recall 
bias of past dietary history, and the inability of the cross-sectional studies to establish a 
cause-and-effect relationship. In addition, the controls in these epidemiological studies should 
ideally be women exposed to HPV infection to enable a fair comparison of the risk of HPV- 




development of cervical cancer has also been overlooked (36). Well-designed controlled 
clinical trials are needed to confirm the observed associations between nutrients and cervical 






High consumption of certain nutrients, vitamins and minerals, particularly those with 
antioxidant and antiviral properties, appears to be effective in preventing HPV infections 
from progressing to high grade CINs. Further evidence from human clinical trials is required 
to confirm the relationship. Health professionals should continue to recommend consumption 
of a wide variety of whole foods rich in these nutrients, vitamins and minerals. Dietary 
supplements should only be taken when these micronutrients are deficit in the food system of 
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APPENDIX: ABBREVIATION LIST 
 
HPV: human papillomarvirus 
 
CIN: cervical intraepithelial neoplasia 
 
DNA: deoxyribonucleic acid 
 
PRISMA: preferred reporting items for systematic review and meta-analyses 
 
USA: United States of America 
 
AP1: activator protein 1 
 






FIGURE 1: Selection process of publications included in this review following the preferred 
reporting items for systematic review and meta-analyses (PRISMA) approach 




TABLE  2:  Association  between  nutrients,  minerals  and  vitamin  intake  and  cervical 
intraepithelial neoplasia (CIN) status 
TABLE  3:  Association  between  circulating  plasma  or  serum  nutrients  and  cervical 
intraepithelial neoplasia (CIN) status 
CHIH TABLE1_1  
 
 
TABLE 1: Association between whole food intake and cervical intraepithelial neoplasia (CIN) status 
 
Study design (Reference) Sample size Food intake Types of CIN Adjusted odds ratio 
 
(95% CI) 
Cross-sectional study in 
 
Shanxi, China (37) 
2338 Among all women,   
≥ 15.95 servings/week of onion vegetables high grade CIN 0.654 (0.437, 0.978) 
≥ 2.69 servings/week of legumes high grade CIN 0.655 (0.439, 0.978) 
0.24-0.60 servings/week of nuts high grade CIN 0.533 (0.359, 0.790) 
≥ 0.61 servings/week of nuts high grade CIN 0.590 (0.394, 0.882) 
≥ 0.94 servings/week of meat high grade CIN 0.651 (0.429, 0.987) 
Among HPV positive women,   
≥16.34 servings/week of onion vegetables high grade CIN 0.589 (0.387, 0.897) 
≥2.81 servings/week of legumes high grade CIN 0.591 (0.392, 0.892) 
0.30-0.60 servings/week of nuts high grade CIN 0.590 (0.395, 0.883) 
≥0.61 servings/week of nut high grade CIN 0.635 (0.426, 0.946) 
≥1.02 servings/week of meat high grade CIN 0.624 (0.406, 0.958) 
Cohort study in Korea 328 Among subjects with HPV viral load ≥ 15.5,   
CHIH TABLE1_2  
 
 






2.84 (1.26, 6.42) 
 
2.93 (1.25, 6.87) 
Cohort study in multi- 
 
European countries   (38) 
299,649 Total fruit invasive cervical cancer hazard ratio for risk: 
 
0.83 (0.72, 0.98) 
Nested Case-control study 
 




carrots (≥ 1 time/year - < 1 time/month) HPV persistent infection 0.30 (0.10, 0.87) 
papaya (≥ 1 time/year - < 1 time/month) HPV persistent infection 0.43 (0.19, 0.97) 
papaya (≥ 1 time/week) HPV persistent infection 0.30 (0.14, 0.64) 
Case-control study in Sao 
 
Paulo, Brazil (40) 




dark-green and deep-yellow 
 
vegetables/fruits (≤ 39 g/day) 
CIN 3 1.71 (1.15, 2.52) 
total fruit and fruit juices (≤ 79 g/day) CIN 3 1.51 (1.05, 2.17) 
total citrus fruit and citrus fruit juices (≤ 79 
 
g/day) 
CIN 3 1.44 (1.02, 2.03) 
total vegetables and fruits (≤ 319 g/day) CIN 3 1.52 (1.06, 2.17) 
Case-control study in Sao 
 
Paulo, Brazil (41) 
99 CIN 1, 95 
 
CIN 2, 185 
 
CIN 3, 82 
carrots (203-1321 g/day) CIN 3 0.50 (0.27, 0.95) 








   










milk (> 5 times/ week) cervical cancer 0.68 (0.48, 0.96) 
bone-edible small fish (> 5 times/ week) cervical cancer 0.46 (0.24, 0.90) 
Case-control study in 
 






>3.01 servings/day of high retinol Thai 
 
foods 
in-situ cervical cancer 0.03 (0.01, 0.14) 
>3.29 servings/day of high total vitamin A 
 
Thai food 
in-situ cervical cancer 0.09 (0.02, 0.50) 
Case-control study in New 
 






vegetables > 80 g/day cervical cancer 0.58 (0.38, 0.89) 
total fruits and vegetables (>139 g/day) cervical cancer 0.52 (0.34, 0.77) 
CHIH TABLE2_1  
 
 
TABLE 2: Association between nutrients, minerals and vitamin intake and cervical intraepithelial neoplasia (CIN) status 
 
Study design ( Reference) Sample size Nutrient, minerals and vitamins 
 
intake 
Types of CIN Adjusted odds ratio 
 
(95% CI) 
Young Women Cohort 
 
study in Arizona, USA (46) 
201 all levels of folate, vitamin B12, vitamin 
 
B6, Methionine 
HPV persistence N.S. 
Young Women Cohort 
 
study in Arizona, USA  (47) 
206 lutein (1042.4-2377.2 µg) HPV infection 0.37 (0.13, 0.82) 
Nested Case-control study 
 






beta-cryptoxanthin HPV persistent infection 0.47 (0.26, 0.85) 
lutein plus zeaxanthin HPV persistent infection 0.49 (0.27, 0.87) 
vitamin C HPV persistent infection 0.50 (0.27, 0.92) 
Case-control study in 
 
Nagoya, Japan (42) 





total calcium (502.6-607.9 mg/day) cervical cancer 0.50 (0.34, 0.73) 
total calcium ≥607.9 mg/day cervical cancer 0.68 (0.48, 0.97) 
total vitamin D ≥291 IU/day cervical cancer 0.64 (0.43, 0.94) 
Case-control study in Korea 144 cervical medium (798-999 RE/day) dietary cervical cancer 0.52 (0.29, 0.92) 
CHIH TABLE2_2  
 
 
(48) cancer cases, 288 
 
controls 
vitamin A   
high (>999 RE/day) dietary vitamin A cervical cancer 0.36 (0.19, 0.69) 
medium (4213-5476 µg/day) dietary 
 
beta-carotene 
cervical cancer 0.51 (0.28, 0.93) 
high (>5476 µg/day) dietary beta- 
 
carotene 
cervical cancer 0.48 (0.26, 0.88) 
>146 mg/day dietary vitamin C cervical cancer 0.36 (0.18, 0.69) 
medium (869-1183 RE/day) total 
 
vitamin A 
cervical cancer 0.51 (0.28, 0.92) 
high (>1183 RE/day) total vitamin A cervical cancer 0.35 (0.19, 0.65). 
>174 mg/day total vitamin C cervical cancer 0.35 (0.19, 0.66) 
>9.67 mg/day total vitamin E). cervical cancer 0.53 (0.28, 0.99) 
Case-control study in New 
 
York, USA (44) 
239 cervical 
 
cancer cases, 979 
controls 
polyunsaturated fat >12 g/day cervical cancer 0.57 (0.34, 0.97) 
dietary fibre >29 g/day cervical cancer 0.59 (0.37, 0.94) 
vitamin C >224 mg/day cervical cancer 0.52 (0.33, 0.80) 
medium vitamin E (5.8-8.9 mg/day) cervical cancer 0.59 (0.40, 0.89) 
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  high vitamin E (>8.9 mg/day) cervical cancer 0.44 (0.27, 0.72) 
medium vitamin A (7421-12786 I.U. 
 
/day) 
cervical cancer 0.55 (0.37, 0.82) 
high vitamin A (>12786 I.U./day) cervical cancer 0.47 (0.30, 0.73) 
medium (595-1393 µg/day) alpha 
 
carotene 
cervical cancer 0.68 (0.47, 0.97) 
high alpha carotene (>1393 µg/day) cervical cancer 0.41 (0.27, 0.63) 
medium beta carotene (3921-7512 
 
µg/day) 
cervical cancer 0.66 (0.46, 0.96) 
high beta carotene (>7512 µg/day) cervical cancer 0.44 (0.29, 0.68) 
medium lutein (3596-6558 µg/day) cervical cancer 0.61 (0.41, 0.89) 
high lutein (>6558 µg/day) cervical cancer 0.51 (0.33, 0.79) 
high lycopene (>5837 µg/day) cervical cancer 0.65 (0.44, 0.98) 
high folate (> 433.2 µg/day) cervical cancer 0.55 (0.34, 0.88) 
Double blind randomised 
 
controlled trial (6 months) 
551 diindolylmethane supplementation CIN2 Relative risk: 0.7 (0.4, 
 
1.2) 
CHIH TABLE2_4  
 
 
in Wales, UK (49)   CIN3 Relative risk: 0.9 (0.4, 
 
2.0) 
N.S.: not significant 
CHIH TABLE3_1  
 
 





Sample size Circulating plasma or serum 
 
nutrients 





in Korea (45) 
58 with CIN, 86 
 
without CIN 
vitamin C CIN Lower in CIN women (p = 
 
0.008) 
malonaldehyde CIN Higher in CIN women (p = 
 
0.002) 





in USA (50) 





alpha-tocopherol CIN Lower in CIN women (p = 
 
0.012) 
alpha tocopheryl quinone CIN and cervical cancer Lower in CIN and cervical 
 
cancer women (p = 0.005) 
Young Women Cohort 
 
study in Arizona, USA 
(46) 
201 vitamin B12 of > 493.2pg/mL HPV persistent infection 0.40 (0.17, 0.96) 
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Cohort study in 
 
Arizona, USA  (51) 
91 folate (5.47-8.79 ng/mL) HPV persistent infection 1.29 (0.27, 6.20) 
folate (8.80-23.44 ng/mL) HPV persistent infection 1.59 (0.33, 7.59) 
vitamin B12 (240.84-444.14 
 
pg/mL) 
HPV persistent infection 1.51 (0.30, 7.54) 
vitamin B12 (444.15-1322.58 
 
pg/mL) 








HPV persistent infection 0.66 (0.12, 3.61) 
Young Women Cohort 
 
study in Arizona, USA 
(52) 
331 Trans-lycopene (0.18-0.263 
 
µg/mL) 
oncogenic HPV clearance Hazard ratio: 3.03 (1.20, 7.65) 




oncogenic HPV clearance Hazard ratio: 3.50 (1.51, 8.08) 
cis-lycopene (> 0.245 µg/mL) oncogenic HPV clearance Hazard ratio: 2.92 (1.28, 6.63) 
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Cohort study in 
 
Hawaii, USA (53) 
122 total trans-lutein/zeaxanthin 
 
(303.93-905.29 ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 1.59 (1.01, 2.51) 
total cryptoxanthin (296.13- 
 
1164.6 ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 1.72 (1.02, 2.88) 
total lycopene (59.31-245.11 
 
ng/mL) 
high-risk HPV infections 
 
clearance 




high-risk HPV infections 
 
clearance 
Hazard ratio: 1.78 (1.03, 3.06) 
total trans beta-carotene (252.16- 
 
1405.5 ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 1.84 (1.13, 2.99) 
cis beta-carotene (23.96-97.36 
 
ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 1.94 (1.20, 3.13) 
Total carotene (379.96-1724.4 
 
ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 1.98 (1.21, 3.23) 
total carotenoids (1755.9-3979.0 
 
ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 1.75 (1.03, 2.97) 
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  total trans-lutein/zeaxanthin 
 
(303.93-905.29 ng/mL) 
high-risk HPV infections 
 
clearance 




high-risk HPV infections 
 
clearance 
Hazard ratio: 4.65 (1.65, 
 
13.09) 
total cryptoxanthin (296.13- 
 
1164.6 ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 3.47 (1.36, 8.87) 
total lycopene (59.31-245.11 
 
ng/mL) 
high-risk HPV infections 
 
clearance 






high-risk HPV infections 
 
clearance 
Hazard ratio: 3.02 (1.07, 8.53) 
total trans beta-carotene (252.16- 
 
1405.5 ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 3.52 (1.44, 8.62) 
cis beta-carotene (23.96-97.36 
 
ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 3.43 (1.18, 9.93) 
total beta-carotene (281.16- 
 
1496.4 ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 3.79 (1.59, 9.00) 
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  Total carotene (379.96-1724.4 
 
ng/mL) 
high-risk HPV infections 
 
clearance 




high-risk HPV infections 
 
clearance 
Hazard ratio: 3.48 (1.33, 9.11) 
total tocopherol (13605-37092 
 
ng/mL) 
high-risk HPV infections 
 
clearance 
Hazard ratio: 3.25 (1.21, 8.71) 
Case-control study in 
 
Bangkok and Choburi, 
Thailand (54) 
44 low grade 
 
CIN cases, 70 
high grade CIN 
cases, 95 
controls 
median serum folate level low grade CIN 
 
high grade CIN 
Lower in low grade CIN cases 
 
(p<0.001) and high grade CIN 
 
cases (p<0.001) 
median red blood cells folate 
 
level 
high grade CIN Lower in high grade CIN 
 
cases (p=0.006) 
folate level <19.82 nmol/L low grade CIN 6.13 (1.80, 20.82) 
folate level <19.82 nmol/L high grade CIN 5.57 (1.70, 18.20) 
folate level (314.89-468.19 
 
nmol/L) 
low grade CIN 0.25 (0.06, 0.98) 
Case-control study in 190 low grade retinol Low grade CIN Lower in low grade CIN cases 
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New Mexico, USA 
 
(55) 
CIN cases, 112 
 
high grade CIN 
cases, 326 
controls 
  (p= 0.001) 
alpha-tocopherol High grade CIN Lower in high grade CIN 
 
cases (p = 0.03) 
retinol level (<0.3186 mg/L) low grade CIN 2.3 (1.3, 4.1) 
retinol level (0.3186-0.384 
 
mg/L) 
low grade CIN 1.9 (1.1, 3.5) 
Case-control study in 
 
New Mexico, USA 
(56) 
81 high grade 
 
CIN cases, 160 
controls 
alpha-carotene level (18.1-87.3 
 
µg/dL) 
CIN 0.46 (0.21, 1.00) 
beta-cryptoxanthin level (10.4- 
 
30.3 µg/dL) 
CIN 0.39 (0.17, 0.91) 
lutein/zeaxanthin (29-76 µg/dL) CIN 0.40 (0.17, 0.95) 
Case-control study in 
 
Sao Paulo, Brazil (40) 




lycopene (≤ 0.40 µmol/L) CIN3 1.88 (1.14, 3.08) 
retinol (≤ 1.49 µmol/L) CIN3 1.51 (1.00, 2.27) 
alpha tocopherol (≤ 2.49 
 
µmol/mmol) 
CIN3 2.87 (1.76, 4.68) 
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  gamma tocopherol (≤ 1.02 
 
µmol/mmol) 
CIN3 1.51 (1.01, 2.24) 
Case-control study in 
 
Sao Paulo, Brazil (41) 
99 CIN 1, 95 
 
CIN 2, 185 CIN 
 
3, 82 cervical 
cancer cases, 
331 controls 
gamma tocopherol (0.96-1.14 
 
µmol/L) 
CIN3 0.44 (0.20, 0.95) 
gamma tocopherol (1.14-1.82 
 
µmol/L) 
CIN3 0.45 (0.21, 0.97) 
lycopene (0.78-1.39 µmol/L) CIN3 0.47 (0.22, 0.99) 
lycopene (1.39-6.30 µmol/L) invasive cervical cancer 0.18 (0.06, 0.52) 










selenium (<97.5 ng/mL) cervical cancer N.S. 
selenium (97.5-106.9 ng/mL) cervical cancer N.S. 
selenium (107-11403.9 ng/mL) cervical cancer N.S. 
selenium (114-124 ng/mL) cervical cancer N.S. 
N.S.: not significant 
